Bibliometric Analysis of TREM2 (2001-2022): Trends, Hotspots and Prospects in Human Disease

Background: Triggering receptor expressed in myeloid cells 2 (TREM2), a transmembrane receptor, has garnered extensive research attention due to its pivotal role in the diagnosis and treatment of various diseases.Despite the abundance of studies on its function, there is a gap in comprehensive analysis and summarization of the current state of this research field.Methods: Articles and reviews related to TREM2 were retrieved from the Web of Science Core Collection (WOSCC) on October 1, 2023.A bibliometric analysis of TREM2 was conducted using CiteSpace, VOSviewer and Bibliometrix (R package).Results: A total of 1,502 articles, spanning from 2001 to 2022, met the search criteria.The number of publications and citations has increased steadily over the years.The United States and China are the most active countries in TREM2 research, with the University of Washington as the leading research institution.The most influential journal in the field is Neurology of Aging.The predominant research areas include molecular, biology and immunology.Alzheimer's disease, microglia, variants, and inflammation are significant keywords.Emerging directions such as metabolism and tumor microenvironment have recently gained attention in numerous studies. Conclusion:The current study utilizes bibliometric analysis software and visual graphics to intuitively highlight TREM2-related hotspots, trends, and prospects in human disease.Such insights are valuable for scholars seeking a deeper understanding of TREM2-related research progress, enabling a focused approach to its application in human disease.